Replies to post #30140 on Biotech Values

[DewDiligence]

>I do not know why you responded to an old post of mine regarding ANDS, re "today's" news.<

Because you posted the ANDS blurb from Business Week’s Gene Marcial. I consider Marcial a contrary indicator (at least in biotech); he tends to pump stocks for reasons that I find mostly vacuous.

>Also, I do not own any shares of ANDS.<

Don’t take it personally.

>Are you also expecting IDIX's CEO to depart for similiar reasons: Albuferon? Or perhaps some other CEO's?<

If that’s a serious question, my answer is no. ANDS was by far the most affected company by the NVS-HGSI deal for Albuferon (#msg-11451803, bottommost paragraph). Regards, Dew